Publikasi Scopus 2024 per tanggal 31 Mei 2024 (409 artikel)

409

Authors

Sukowati C.H.; El-Khobar K.; Jasirwan C.O.M.; Kurniawan J.; Gani R.A.

Author_Full_Names

Sukowati, Caecilia HC (26653855800); El-Khobar, Korri (55969199100); Jasirwan, Chyntia Olivia Maurine (55192478000); Kurniawan, Juferdy (57193251655); Gani, Rino Alvani (23495930300)

Author S Id

26653855800; 55969199100; 55192478000; 57193251655; 23495930300

Title

Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?

Year

2024

Source Title

Annals of Hepatology

Volume

Issue

Art No

101153

Page Start

Page End

Page Count

Cited By

Link

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85173150306&doi=10.1016%2fj.aohep.2023.101153&partnerID=40&md5=974748f418af439423c1070b4116a6ef

Affiliations

Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park campus Basovizza, SS14 km 163.5, Trieste, 34149, Italy; Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), B.J. Habibie Building, Jl. M.H. Thamrin No. 8, Jakarta Pusat, 10340, Indonesia; Hepatobiliary Division, Medical Staff Group of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jl. Pangeran Diponegoro No.71, Jakarta, 10430, Indonesia

Authors With Affiliations

Sukowati C.H., Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park campus Basovizza, SS14 km 163.5, Trieste, 34149, Italy, Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), B.J. Habibie Building, Jl. M.H. Thamrin No. 8, Jakarta Pusat, 10340, Indonesia; El-Khobar K., Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), B.J. Habibie Building, Jl. M.H. Thamrin No. 8, Jakarta Pusat, 10340, Indonesia; Jasirwan C.O.M., Hepatobiliary Division, Medical Staff Group of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jl. Pangeran Diponegoro No.71, Jakarta, 10430, Indonesia; Kurniawan J., Hepatobiliary Division, Medical Staff Group of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jl. Pangeran Diponegoro No.71, Jakarta, 10430, Indonesia; Gani R.A., Hepatobiliary Division, Medical Staff Group of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jl. Pangeran Diponegoro No.71, Jakarta, 10430, Indonesia

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers with a high mortality rate. HCC development is associated with its underlying etiologies, mostly caused by infection of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV), alcohol, non-alcoholic fatty liver disease, and exposure to aflatoxins. These variables, together with human genetic susceptibility, contribute to HCC molecular heterogeneity, including at the cellular level. HCC initiation, tumor recurrence, and drug resistance rates have been attributed to the presence of liver cancer stem cells (CSC). This review summarizes available data regarding whether various HCC etiologies may be associated to the appearance of CSC biomarkers. It also described the genetic variations of tumoral tissues obtained from Western and Eastern populations, in particular to the oncogenic effect of HBV in the human genome. © 2023 Fundación Clínica Médica Sur, A.C.

Author Keywords

Biomarkers; Cancer stem cells; Etiology; Hepatocellular carcinoma; Stem cells

Index Keywords

Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; aflatoxin; aflatoxin B1; tumor marker; alcoholic fatty liver; cancer diagnosis; cancer mortality; cancer stem cell; cell stemness; disease association; DNA polymorphism; gene mutation; genetic association; genetic heterogeneity; genetic susceptibility; genetic variability; Hepatitis B virus; Hepatitis C virus; high throughput sequencing; human; liver cell carcinoma; mortality rate; nonalcoholic fatty liver; nonhuman; race difference; Review; chronic hepatitis B; complication; genetics; hepatitis B; hepatitis C; liver cell carcinoma; liver tumor; pathology; tumor recurrence

Funding Details

Fondazione Umberto Veronesi

Funding Text

CHCS is supported by 2022-2023 grant of the Fondazione Umberto Veronesi, Milan, Italy. KEEK received a fellowship of the Ministero degli Affari Esteri e della Cooperazione Internazionale (MAECI) of Italy for the Progetto Co-Tutela at the FIF.

Publisher

Elsevier Espana S.L.U

Issn

16652681

Isbn

Pubmed Id

37734662

Document Type

Review

Sjr Best Quartile

Sjr

859

Sjr Rank

5362